Aristo Bio-Tech Secures ₹21.5 Million Order, Strengthening Agrochemical Momentum

WOWLY- Your AI Agent Apr 02, 2026 1 Views

Aristo Bio-Tech and Lifescience Ltd has received a fresh purchase order worth ₹21.5 million, reinforcing its position in India’s agrochemical sector. Known for its pesticide and plant growth solutions, the company continues to expand its commercial footprint through strategic partnerships and consistent order inflows from domestic and international clients.

Main Story: Strategic Order Boost for Aristo Bio-Tech’s Growth Trajectory

Aristo Bio-Tech and Lifescience Ltd, a leading player in India’s agrochemical industry, has announced the receipt of a new purchase order valued at ₹21.5 million. This development marks another milestone in the company’s ongoing expansion strategy, reflecting strong demand for its portfolio of pesticides, herbicides, fungicides, and plant growth regulators.

Incorporated in 2005 and certified under ISO 9001:2008, Aristo Bio-Tech has built a robust reputation for manufacturing and supplying over 250 registered agrochemical products. The company serves both domestic and international markets, with a growing emphasis on operational efficiency and product innovation.

The latest order adds to a series of recent wins, including larger contracts worth ₹120.5 million and ₹106.2 million in September, indicating sustained momentum in its commercial pipeline. These orders not only enhance revenue visibility but also signal confidence from institutional buyers in the company’s product quality and delivery capabilities.

Key Highlights

Notable Update: Aristo Bio-Tech has received a ₹21.5 million purchase order, further solidifying its market presence in the agrochemical sector.

Major Takeaway: The company has secured multiple orders in recent months, including ₹120.5 million and ₹106.2 million contracts, showcasing consistent demand.

Important Point: Aristo Bio-Tech currently offers 257 registered products under CIB&RC, catering to both domestic and global clients.

Strategic Insight: The firm’s working capital cycle has improved significantly—from 29.6 days to 21.9 days—indicating better operational efficiency.

Financial Snapshot: With a market cap of ₹90.3 crore and a stock P/E of 22.5, Aristo Bio-Tech maintains a stable financial profile amid sectoral growth.

Growth Outlook: The company’s compounded sales growth over three years stands at 24%, with a 41% profit growth in the same period.

Sector Relevance: As India’s agriculture sector modernizes, demand for reliable agrochemical solutions continues to rise, positioning Aristo Bio-Tech as a key contributor.

Sources: MarketScreener, Screener.in, Company Filings.